PMC:5848821 / 27309-27818 JSONTXT

{"project":"TEST0","denotations":[{"id":"28449028-166-171-6744","span":{"begin":166,"end":167},"obj":"[\"24842578\"]"},{"id":"28449028-224-230-6745","span":{"begin":420,"end":422},"obj":"[\"24657034\"]"}],"text":"Five-year OS of patients undergoing resection for pleural dissemination of TETs in studies with 5 to 21 patients was recently reviewed and ranges from 43.1 to 92.3% [3]. In a recent retrospective study on behalf of the Japanese Association for Research on the Thymus on 136 patients who underwent surgical resection for TETs with pleural dissemination, Masaoka Stage IVA (n = 118) and IVB (n = 18), 5-year OS was 83.5% [11]. OS of the entire patient cohort in the current study compares favourably with 87.2%."}

{"project":"0_colil","denotations":[{"id":"28449028-24842578-6744","span":{"begin":166,"end":167},"obj":"24842578"},{"id":"28449028-24657034-6745","span":{"begin":420,"end":422},"obj":"24657034"}],"text":"Five-year OS of patients undergoing resection for pleural dissemination of TETs in studies with 5 to 21 patients was recently reviewed and ranges from 43.1 to 92.3% [3]. In a recent retrospective study on behalf of the Japanese Association for Research on the Thymus on 136 patients who underwent surgical resection for TETs with pleural dissemination, Masaoka Stage IVA (n = 118) and IVB (n = 18), 5-year OS was 83.5% [11]. OS of the entire patient cohort in the current study compares favourably with 87.2%."}

{"project":"2_test","denotations":[{"id":"28449028-24842578-28904951","span":{"begin":166,"end":167},"obj":"24842578"},{"id":"28449028-24657034-28904952","span":{"begin":420,"end":422},"obj":"24657034"}],"text":"Five-year OS of patients undergoing resection for pleural dissemination of TETs in studies with 5 to 21 patients was recently reviewed and ranges from 43.1 to 92.3% [3]. In a recent retrospective study on behalf of the Japanese Association for Research on the Thymus on 136 patients who underwent surgical resection for TETs with pleural dissemination, Masaoka Stage IVA (n = 118) and IVB (n = 18), 5-year OS was 83.5% [11]. OS of the entire patient cohort in the current study compares favourably with 87.2%."}

{"project":"MyTest","denotations":[{"id":"28449028-24842578-28904951","span":{"begin":166,"end":167},"obj":"24842578"},{"id":"28449028-24657034-28904952","span":{"begin":420,"end":422},"obj":"24657034"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Five-year OS of patients undergoing resection for pleural dissemination of TETs in studies with 5 to 21 patients was recently reviewed and ranges from 43.1 to 92.3% [3]. In a recent retrospective study on behalf of the Japanese Association for Research on the Thymus on 136 patients who underwent surgical resection for TETs with pleural dissemination, Masaoka Stage IVA (n = 118) and IVB (n = 18), 5-year OS was 83.5% [11]. OS of the entire patient cohort in the current study compares favourably with 87.2%."}

{"project":"testtesttest","denotations":[{"id":"T79","span":{"begin":260,"end":266},"obj":"Body_part"}],"attributes":[{"id":"A79","pred":"uberon_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/UBERON_0002370"}],"text":"Five-year OS of patients undergoing resection for pleural dissemination of TETs in studies with 5 to 21 patients was recently reviewed and ranges from 43.1 to 92.3% [3]. In a recent retrospective study on behalf of the Japanese Association for Research on the Thymus on 136 patients who underwent surgical resection for TETs with pleural dissemination, Masaoka Stage IVA (n = 118) and IVB (n = 18), 5-year OS was 83.5% [11]. OS of the entire patient cohort in the current study compares favourably with 87.2%."}